Non-inferiority Comparison of Efficacy and Safety of Penciclovir 10mg/g to Acyclovir 50mg/g in the Treatment of Recurrent Herpes Labialis

Exclusion Criteria

• •1. Pregnancy or risk of pregnancy.
• •2. Lactation
• •3. Use of anti-inflammatory or immunosuppressive drugs (last 30 days prior to the study.)
• •4. Sunlight over exposure in the last 15 days.
• •5. Any pathology or past medical condition that can interfere with this protocol.
• •6. AINH use, hormonal anti-inflammatory, analgesic and immunosuppressive drugs (in the last 30 days and during the study);
• •7. Patients with immunodeficiency and/or immunosuppressive disease;
• •8. Sunlight exposure in the last 15 days;
• •9. Hypersensitivity to components of the formula;
• •10. Other conditions deemed reasonable by the medical investigator as to the disqualification of the individual from study participation.